Cigna Group (NYSE:CI) made a decisive move to bolster its leadership in Asia Pacific with the appointment of Rob Peat as CEO, effective April 2025, focusing on growth acceleration across key regions.

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Leon Cooperman’s portfolio grew to $2.64B with shifts in top holdings, new stakes in KBR & Las Vegas Sands, and notable ...

MARPAI EXHIBITS STRONG, ONGOING FINANCIAL IMPROVEMENT TAMPA, Fla., March 26, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology ...

StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...

Cigna Group closed 13.37% below its 52-week high of $370.83, which the company achieved on September 16th.

we note the average price per share of these sales and the stock’s market capitalization. The Cigna Group (NYSE:CI) is a global health services company offering insurance and healthcare ...

With each stock, we note the average price per share of these sales and the stock’s market capitalization. The Cigna Group (NYSE:CI) is a global health services company offering insurance and ...